- Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice
- The relevance of a digestibility evaluation in the allergenicity risk assessment of novel proteins. Opinion of a joint initiative of COST action ImpARAS and COST action INFOGEST
- Systems approach for classifying the response to biological therapies in patients with rheumatoid arthritis in clinical practice
- Purification and Characterization of Naturally Occurring Post-Translationally Cleaved Ara h 6 an Allergen That Contributes Substantially to the Allergenic Potency of Peanut
- A fungal biofilm reactor based on metal structured packing improves the quality of a Gla::GFP fusion protein produced by Aspergillus oryzae
- The ultimate radiochemical nightmare: Upon radio-iodination of Botulinum neurotoxin A, the introduced iodine atom itself seems to be fatal for the bioactivity of this macromolecule
- Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia
- The minipig as an alternative non-rodent model for immunogenicity testing using the TNFα blockers adalimumab and infliximab
- Toll-like receptor 2 activation by β2→1-fructans protects barrier function of t84 human intestinal epithelial cells in a chain length-dependent manner
- Sizing up large protein complexes by electrospray ionisation-based electrophoretic mobility and native mass spectrometry: Morphology selective binding of Fabs to hepatitis B virus capsids
- PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE
- The Göttingen minipig® as an alternative non-rodent species for immunogenicity testing: A demonstrator study using the IL-1 receptor antagonist anakinra
- Exploring an orbitrap analyzer for the characterization of intact antibodies by native mass spectrometry